This site uses cookies. By using this site you agree to receiving cookies. View Policy.

Cell Guidance Systems is developing a patented technology to unlock the medical potential of growth factor proteins. PODS enables proteins to treat diseases, such as Parkinson's disease and osteoarthritis, by improving their delivery to the disease site. The technology addresses multi-$bn markets.

  • Amount raised (£)

    £1,127,280

  • Company number

    07122793

  • Incorporation date

    12/01/2010

  • Total investors

    1,000

Details

  • Company number

    07122793

  • Incorporation date

    12/01/2010

  • Company status

    Active

  • Industry type

    Research and experimental development on biotechnology

  • Number of current appointments

    3

Maia Building,
Babraham Research Campus
Cambridge
CB22 3AT

Crowdcube Funding History

Date Amount No. of Investors
08/05/2018 £836,370 862 View
17/09/2013 £290,910 138 View

Key Financials

View all financials
2019 2020
Turnover - -
Cash £260.08k £282.46k
Increase in Cash - -

Financial data drawn from last filed accounts don't necessarily reflect current trading activity.

Date Description Type
06/10/2021

Resolutions

PDF
04/06/2021

Total exemption full accounts made up to 2020-12-31

PDF
07/01/2021

Confirmation statement made on 2020-12-31 with updates

PDF

People

Name Role Appointed Nationality
JONES, Michael Howard, Dr Director 10/01/2010 British
KERINS, Michael Director 10/06/2010 British
TREHERNE, Jonathan Mark, Dr Director 15/10/2015 United Kingdom